NR1H4 and inflammatory bowel disease: In IBD, for example, alterations in BA metabolism can result in increased levels of primary BAs and decreased level of secondary BAs [68], which may contribute to the dysregulation of BA receptors like the Farnesoid X receptor (FXR).